john hawks weblog

paleoanthropology, genetics and evolution

biotech

  • Sex, steroids and sport

    Sun, 2012-05-06 12:18 -- John Hawks

    The Guardian is giving us some pre-London-Olympic buildup, including an interesting article about the impact of strategies to make female athletes more like males: "The rise of performance-enhancing genes".

    While not necessarily agreeing with this statement quantitatively, qualitatively it is sound. Female world and Olympic records set prior to random drug testing have been much harder to break. For example, while there is a steady progression in the male Olympic athletic records, there are as many female Olympic records still standing that were set prior to 1990 as those that were set in the last decade. It is hard not to argue with the implication that the steroid doping that was widespread in the 1980s has had a more dramatic effect in female sport than male sport.

    I also did not know the story of Dora Ratjen, a gender-ambiguous German athlete and 1938 female European high jump champion.

  • Gene doping mice

    Sat, 2012-03-17 20:32 -- John Hawks

    Andy Coghlan reports on work using viral vectors to amp up mouse muscles, a form of "gene doping", in New Scientist: "Blood tests won't stop gene cheats".

    Autopsies showed that the extra IGF-1 triggered the production of 10 times more protein than normal in the muscles. Giacca also saw activity soar in genes controlling energy production, contraction of muscles and respiration. Also detectable in the muscle were traces of the virus used to deliver the genes. However, the gene, protein and virus were undetectable in blood or urine from the mice (Human Gene Therapy, DOI: 10.1089/hum.2011.157).

    Writing this sent me looking through my "gene doping" archives. This from 2006, where I reacted to fears that athletes in the Beijing Olympics might be using viral vectors to amp themselves: "Is the dawn of "gene doping" at hand?"

    But there is a total lack of recognition of a basic reality: Somebody who actually could figure out how to genetically enhance an athlete before 2008 probably deserves a Nobel prize! And if they could figure that out, they would be a paid a whole lot more by applying their 'l33t genetic skillz curing osteoporosis or something.

    I mean, even Zorin's doctor had that whole residual-Third-Reich-loyalty keeping him in the game.

    I'm pretty sure that snark will shorten my life a lot more than red meat ever could.

  • Finding the scary genes

    Wed, 2012-03-07 21:39 -- John Hawks

    John Lauerman reports in BusinessWeek on his experience participating in the Personal Genome Project:

    “This is probably the most serious variant that we’ve actually seen to date in the study,” Thakuria said. About two out of 1,000 people have the JAK2 variant, which encourages blood cells to grow and divide. The variant is used to diagnose three rare blood disorders, including primary myelofibrosis, which is potentially lethal. “I don’t want you to fret about this,” Thakuria said, before giving me fresh cause for worry: a study, published in 2010, in which 10,507 people in Copenhagen gave blood samples and were followed for as long as 18 years. The Copenhagen researchers went back and analyzed the blood samples: 18 had the JAK2 variant; 14 of those 18 with the variant developed cancer in their lifetimes, and all 18 died within the study period. How, exactly, was this helping?

    Finding that you carry a harmful genetic variant, and that there's nothing you can do about it, is probably the most frightening outcome when obtaining your personal genetic information. Some say they would rather not know about such genes.

    Several others have commented on Lauerman's piece, including Matthew Herper at Forbes, and the 23andMe blog. Naturally, they have different takes.

  • Ancestry perspective from 23andMe

    Sun, 2012-03-04 13:42 -- John Hawks

    Stanford geneticist Joanna Mountain recounts some of the experience she brings to 23andMe in her role as Senior Director of Research: "Solving mysteries via DNA". Much of her interests are the anthropological aspects of DNA and ancestry.

    Now that we know how DNA aligns with prehistoric migrations, we can trace the DNA of individuals to northern Europe or Central Asia, South America or the Near East, western Africa or Oceania. That information about where DNA is from can, in turn, answer questions about our ancestors. Were they struggling to feed their children through hunting red deer in northern Europe, harvesting shellfish in southeastern Asia, raising alpacas in the highland plateaus of western South America, or digging for tubers in eastern Africa? DNA shows that some of us have ancestors who faced the challenge of survival using several of these strategies.

    A new round of "Finding Your Roots With Henry Louis Gates, Jr" is going to begin on PBS this month, using 23andMe services as part of the program.

  • Genotyping the intro class

    Fri, 2012-02-24 00:26 -- John Hawks

    Holly Dunsworth, at the University of Rhode Island, is undertaking a unique project with her undergraduate course this semester, providing 23andMe genotyping for every student. She describes some of her thoughts on the "cans of worms" that this may create for her: "First we were snapped, now we're SNP'd".

    Part of what students have to do this semester is form a 'plan of action.' That's what I've called their assignment where they predict what their SNPs will hold and where they explain what they will do if they find out they're at high risk for a disease or even, yes, that they might not be related to their father. (This discovery doesn't require paternal DNA. Since half of your genome is from your father, and since a few traits are pretty simple, the rare participant with the rare SNP can deduce that they did not get their DNA from their father who doesn't show the trait in question.)

    I've been discussing this issue a lot with people lately. In a few years, most of my students will have whole-genome genotyping or sequencing done for routine medical purposes, because that's how cheap it will be. Interpretation of the results will not (necessarily) be cheap, and it may not be appreciably better than it is now.

    Some readers will say, "Well, if the interpretation isn't a lot better than now, nobody will want the results anyway, so it won't happen."

    I disagree. Take Mendelian disorders. Today, every child in Wisconsin is tested for a few dozen genetic disorders at birth. It is already possible to screen parents for every Mendelian disorder with a frequency of more than one in a thousand. In a short time, that genotyping will be cheaper than the current postnatal testing. Prenatal care already includes a score of tests, and fetal cell genotyping may eventually replace postnatal testing for genetic disorders. Moreover, companies (for example, Counsyl) are already providing genotyping and interpretive services for the couples prenatal testing market. As genotyping becomes cheaper, it will pull in a broader and broader fraction of my students, future college graduates and professionals.

    So I've taken it as my attitude that my biological anthropology courses must educate them for this future. Our curricula can provide the students useful information about health and ancestry, including both the promise and limits of genetic information. The beauty of the new genetic approaches is that they provide better illustrations of most of the classic topics in human biology and variation. You can see some of that at play in my Principles of Biological Anthropology lectures this semester.

    Synopsis: 
    Holly Dunsworth shares some perspective on 23andMe testing for her students
  • Genetics and privacy

    Tue, 2012-02-14 08:17 -- John Hawks

    "Harvard prof Henry Louis Gates Jr. hunting for great-great grandfather"

    CUMBERLAND, Md. -- Harvard University Professor Henry Louis "Skip" Gates Jr. is asking all residents of Allegany County, Maryland, who are of Irish descent to get their DNA tested to help solve a 150-year-old family mystery -- who is Gates’ great-great grandfather?

    I admire the way Henry Louis Gates has rolled with the punches as genealogical data from genetics have changed over the years. In 2006, I wrote in Slate about the limits of DNA ancestry testing, using Gates as an example of how tests before that time could mislead ("How African are you?"). He has made the complexity of interpreting these genealogy assessments into a successful series of television specials, and has probably done more to popularize DNA-assisted genealogy than anyone else in the United States.

    I thought of this story when Razib blogged today about "red tape" as a barrier to genetic testing for the purposes of health research ("American medicine & American red-tape").

    People are suffering from terminal illnesses, and considerations of the genetic privacy of their near relatives are looming large? Seriously? The reality is that manifestation of a disease itself gives one information about the risks of their relatives.

    The reality of genetics today: A Harvard professor is collecting the DNA of all Irish-descent males in Allegany County, Maryland, for the purposes of finding a man who lived in 1820. And many of them are willingly cooperating.

    "Privacy advocates" seem like they're living in the 1980's. Of course, when you end up dealing with Congress, the FDA, or other branches of government, living in the 80's is the expected norm.

  • Exome sequencing into Norway national health care

    Sat, 2012-02-04 10:24 -- John Hawks

    From Ewen Callaway: "Norway is set to become the first country to incorporate genome sequencing into its national health-care system."

    In its three-year pilot phase, the Norwegian Cancer Genomics Consortium will sequence the tumour genomes of 1,000 patients in the hope of influencing their treatments. It will also look at another 3,000 previously obtained tumour biopsies to get a better idea of the mutations in different cancers, and how they influence a patient's response to a drug. In a second phase, the project will build the laboratory, clinical and computing infrastructure needed to bring such care to the 25,000 Norwegians who are diagnosed with cancer each year.

    Expect to see much, much more of this.

  • Synthetic biology explainer

    Sat, 2012-01-14 14:47 -- John Hawks

    Nice piece on synthetic biology by Adam Rutherford:

    But Freckles is a long way from normal. She is an extraordinary creation, an animal that could not have existed at any point in history before the 21st century. She is all goat, but she has something extra in every one of her cells: Freckles is also part spider.

    UPDATE (2012-01-14): A knowledgeable reader writes:

    Ah, journalists! What do transgenic animals have to do with synthetic biology? Absolutely nothing, in fact. And the hyperbole fails, too. If the protein was human instead of arachnid (as is the with many cows now), that goat would be part human then? Which would then mean that a lot of bacterial, insect and mouse cells I grow in the lab are part human, too! Woo-hoo! Meet Dima Klenchin, a synthetic biologist...

    And Venter Institute's bacterium is not a synthetic life by any stretch of imagination and neither is anything else described in the article (modifying microorganisms for industrial production is about two decades old news). In fact, "synthetic biology" seems to be simply a new buzz word to get funding easier. You see, "transgenic organisms" is getting too routine and stale from the funding point of view and "nanotechnology" too has been overused to the point of losing much of its buzz power as well. So pharmacology is now "chemical biology" and gene engineering is now "synthetic biology".

    As for the truly synthetic life, we are finding that it is a very hard going. Everyone would be enormously impressed by a single brand new enzyme or a metabolic pathway (no aping from existing prototypes in nature). Alas, even that turns out to be easier said than done. But fear not - all those computer scientists and physicists will soon, veeeery soon, come to the rescue. :-)

    I thought it was a fun article but your points are well taken. I think that there is a faction who are trying to "define down" the term synthetic biology so it applies to everything from recombinant DNA upward. Venter obviously hasn't helped matters by trying to lower the bar for an artificial life form.

    But maintaining any useful distinction may become impossible anyway if molecular machines can be made to interact in any useful way with endogenous genomes. Of course if they make spider silk comes straight out the goat's udder it would be more awesome than tomacco!

  • The Mayflower criminal registry

    Fri, 2012-01-13 22:25 -- John Hawks

    Of some interest with respect to DNA databases and privacy concerns: "DNA links 1991 killing to Colonial-era family".

    The DNA sample was taken in the death of 16-year-old Sarah Yarborough, who was killed on her high school campus in Federal Way, Washington, in December 1991. The King County Sheriff's Office has circulated two composite sketches of a possible suspect -- a man in his 20s at the time with shoulder-length blonde or light brown hair -- but had been unable to put a name to the sketch.

    In December, though, the department sent the DNA profile to California-based forensic consultant Colleen Fitzpatrick. Fitzpatrick compared the profile to others in genealogy databases and found the closest match was to the family of Robert Fuller, who settled in Salem, Massachusetts, in 1630 and had relatives who came over before him on the Mayflower.

    This is a Y chromosome match based on the genealogical research of people who may be completely unknown to the "suspect". Fitzpatrick offers that a Y-chromosome match may be expected to share a surname, which is probative in the forensic situation. Obviously there are many possible scenarios in which such information will not lead to discovery of a suspect: the chance of non-acknowledged paternity events across 200 years is very high. I don't view the result as strongly actionable, but I do think it raises important questions about the future of genealogy databases.

    We are near the time when whole-genome sequencing will make this kind of identification much more likely because unique genetic matches to 3rd and 4th degree relatives will be plausible. Finding a handful of rare mutations shared between a crime scene sample and an individual in a whole-gneome database would be a strong indication of a relationship. It's possible that the databases for whole genomes will grow faster than the technology will allow reliable whole-genome sequencing from a crime scene sample. So in this case, the issues with database use may be primary.

    It would be an interesting exercise to estimate the fraction of unknown samples from crime scene Y chromosome and mtDNA that could be matched to a 10th-degree relative in the Genographic (or any other large) dataset.

  • A quick look at your Neandertal fraction

    Fri, 2011-12-16 15:13 -- John Hawks

    The 23andMe blog, the Spittoon, has a description of their new technique to use 23andMe SNPs to estimate any customer's fraction of Neandertal: "Find your inner Neanderthal".

    The result is a rough-and-ready numerical estimate of your Neandertal ancestry fraction. For me it's 2.5 percent. Gretchen is 3 percent, and she's been lording it over me all day.

    The estimate is the work of Eric Durand, who broke ground on the D-statistic method for finding introgression from archaic genomes [1]. He has made public a short white paper describing the application.

    So far, all estimates of Neandertal (or other archaic human) ancestry have come from the proportion of a genome (or genotypes from a genome) that are shared and derived with Neandertals. That includes the results I've been posting here for the 1000 Genomes Project samples this week.

    The next step is to uncover exactly which parts of a person's genome have come from Neandertal ancestors. To discover this, we have to further determine which shared alleles come from recent introgression as opposed to ancient incomplete lineage sorting. We have been working very hard on that problem here, as you'll see, and it has been an important aspect of our work in pigmentation genes in the archaic genomes.

    If you have been considering getting your genotypes from 23andMe, it has become a very good time to do this. The overall fraction of your DNA derived from Neandertals is only the beginning. Soon we'll be able to specify which parts, and in a few cases we'll have a good guess as to what difference it makes. If you want to participate in this research, I'm hoping to gather as many interested people as I can -- so keep your eyes here over the next month.

    And if you are interested in having your genotypes done, feel free to use my link to the 23andMe promotion. I've been very happy with their way of presenting the genotypes and their updates, and know many other people who have also found it interesting. As I wrote a couple of years ago, it's not something to spend your food money on, but it does have an entertainment value. And the potential to be an active research participant.


    References

Pages

Subscribe to biotech

Neandertals

For years, I've worked on their bones. Now I'm working on their genes. Read more about the science studying these ancient people.

Denisova

From a finger bone of an ancient human came the record of a completely unexpected population. My lab is working on the science of the Denisova genome.

Acceleration

The advent of agriculture caused natural selection to speed up greatly in humans. We're uncovering some of the ways that populations have rapidly changed during the last 10,000 years.

Malapa

Just outside Johannesburg, the Malapa site is producing some of the most exciting finds in human evolution. This site is the headquarters of the Malapa Soft Tissue Project.